News category:
Thursday, December 19, 2019
During the December 10th Regulatory Affairs Committee meeting the committee members drafted a template that excipient companies can use in response to inquiries from pharma companies trying to address nitrosamine concerns. Please visit the Document Depot>Resources>Hot Topics>Nitrosamines folder in order to download the template. You must be logged in to access the template.